Zobrazeno 1 - 10
of 394
pro vyhledávání: '"Juan J Gomez Reino"'
Autor:
Christopher T. Ritchlin, Jon T. Giles, Alexis Ogdie, Juan J. Gomez‐Reino, Philip Helliwell, Pamela Young, Cunshan Wang, Joseph Wu, Ana Belén Romero, John Woolcott, Lori Stockert
Publikováno v:
ACR Open Rheumatology, Vol 2, Iss 10, Pp 543-554 (2020)
Objective Metabolic syndrome (MetS) is a cluster of concurrent risk factors for cardiovascular disease and type 2 diabetes. This post hoc analysis explored key efficacy and safety endpoints in patients with psoriatic arthritis (PsA) and MetS treated
Externí odkaz:
https://doaj.org/article/fc2e3eed87934869ad35765b8844ae75
Autor:
Philip J. Mease, Dafna D. Gladman, Juan J. Gomez‐Reino, Stephen Hall, Arthur Kavanaugh, Eric Lespessailles, Georg Schett, Maria Paris, Nikolay Delev, Lichen Teng, Jürgen Wollenhaupt
Publikováno v:
ACR Open Rheumatology, Vol 2, Iss 8, Pp 459-470 (2020)
Objective Psoriatic arthritis (PsA) requires long‐term treatment, yet safety concerns and monitoring requirements make maintenance a challenge. This analysis of pooled Psoriatic Arthritis Long‐term Assessment of Clinical Efficacy (PALACE) 1, 2, a
Externí odkaz:
https://doaj.org/article/fa93086f13fa47d6bce83b4a9731f08f
Autor:
Aida Ferreiro-Iglesias, Ariana Montes, Eva Perez-Pampin, Juan D Cañete, Enrique Raya, Cesar Magro-Checa, Yiannis Vasilopoulos, Rafael Caliz, Miguel Angel Ferrer, Beatriz Joven, Patricia Carreira, Alejandro Balsa, Dora Pascual-Salcedo, Francisco J Blanco, Manuel J Moreno-Ramos, Sara Manrique-Arija, María Del Carmen Ordoñez, Juan Jose Alegre-Sancho, Javier Narvaez, Federico Navarro-Sarabia, Virginia Moreira, Lara Valor, Rosa Garcia-Portales, Ana Marquez, Juan J Gomez-Reino, Javier Martin, Antonio Gonzalez
Publikováno v:
PLoS ONE, Vol 14, Iss 2, p e0213073 (2019)
Research in rheumatoid arthritis (RA) is increasingly focused on the discovery of biomarkers that could enable personalized treatments. The genetic biomarkers associated with the response to TNF inhibitors (TNFi) are among the most studied. They incl
Externí odkaz:
https://doaj.org/article/63ceff512b484958947a7084dbdd2f7e
Autor:
Rosario Lopez-Rodriguez, Eva Perez-Pampin, Ana Marquez, Francisco J Blanco, Beatriz Joven, Patricia Carreira, Miguel Angel Ferrer, Rafael Caliz, Lara Valor, Javier Narvaez, Juan D Cañete, Maria Del Carmen Ordoñez, Sara Manrique-Arija, Yiannis Vasilopoulos, Alejandro Balsa, Dora Pascual-Salcedo, Manuel J Moreno-Ramos, Juan Jose Alegre-Sancho, Federico Navarro-Sarabia, Virginia Moreira, Rosa Garcia-Portales, Enrique Raya, Cesar Magro-Checa, Javier Martin, Juan J Gomez-Reino, Antonio Gonzalez
Publikováno v:
PLoS ONE, Vol 13, Iss 5, p e0196793 (2018)
Genetic biomarkers are sought to personalize treatment of patients with rheumatoid arthritis (RA), given their variable response to TNF inhibitors (TNFi). However, no genetic biomaker is yet sufficiently validated. Here, we report a validation study
Externí odkaz:
https://doaj.org/article/81eb385d7e2649958830718e9afb63b9
Autor:
Laura Vidal-Bralo, Eva Perez-Pampin, Cristina Regueiro, Ariana Montes, Rosana Varela, Maria Dolores Boveda, Juan J Gomez-Reino, Antonio Gonzalez
Publikováno v:
PLoS ONE, Vol 12, Iss 7, p e0180144 (2017)
Patients with rheumatoid arthritis (RA) have an increased mortality rate that is associated with the presence of RA-specific autoantibodies in many studies. However, the relative role of rheumatoid factor (RF), anti-CCP antibodies and the most recent
Externí odkaz:
https://doaj.org/article/364af557af734ea4923e2e5a99db84b5
Autor:
José Vicente Moreno Muelas, Miguel Ángel Abad Hernández, Federico Díaz-González, Juan J. Gomez-Reino, Alejandro Balsa Criado, Rubén Queiro Silva, José Luis Andreu
Publikováno v:
Reumatología Clínica. 17:160-169
espanolEn el ano 2015 la Sociedad Espanola de Reumatologia (SER) publico su posicionamiento sobre farmacos biosimilares. En esta actualizacion, la SER, sigue manifestando su compromiso inequivoco con la sostenibilidad del sistema sanitario de nuestro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f9b1939b57c984e3a6f28450660f1cd5
https://doi.org/10.1016/j.reuma.2019.03.007
https://doi.org/10.1016/j.reuma.2019.03.007
Autor:
Miguel Ángel Abad Hernández, Alejandro Balsa Criado, Rubén Queiro Silva, Juan J. Gomez-Reino, Federico Díaz-González, José Vicente Moreno Muelas, José Luis Andreu
Publikováno v:
Reumatología Clínica (English Edition). 17:160-169
In 2015 the Spanish Society of Rheumatology (Sociedad Espanola de Reumatologia [SER]) published its position paper on biosimilar drugs. In this update, the SER, continues to manifest its unequivocal commitment to the sustainability of the health syst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b955255ad35d46d161630983d9464fa
https://doi.org/10.1016/j.reumae.2019.03.003
https://doi.org/10.1016/j.reumae.2019.03.003
Publikováno v:
Patient preference and adherence
Manuel Pombo-Suarez,1 Jose Ramon Maneiro Fernandez,2 Juan Jesus Gomez-Reino3 1Rheumatology Service, Complejo Hospitalario Universitario, Santiago de Compostela, Spain; 2Rheumatology Service, Complejo Hospitalario Universitario, Pontevedra, Spain; 3Fu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff92e4c46ec5191f62e2d00af0356861
https://doi.org/10.2147/ppa.s291983
https://doi.org/10.2147/ppa.s291983
Autor:
Ariana Montes, Cristina Regueiro, Eva Perez-Pampin, Maria Dolores Boveda, Juan J Gomez-Reino, Antonio Gonzalez
Publikováno v:
PLoS ONE, Vol 11, Iss 8, p e0161141 (2016)
A large fraction of the patients with rheumatoid arthritis (RA) develop specific autoantibodies, which until recently were only of two types, rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPA). We aimed to replicate important fin
Externí odkaz:
https://doaj.org/article/b88cd1f51d4c491d83a268c6377d0766
Autor:
Juan J. Gomez-Reino, Stephen Hall, Philip J. Mease, Georg Schett, N. Delev, Dafna D. Gladman, L. Teng, Eric Lespessailles, Jürgen Wollenhaupt, Maria Paris, Arthur Kavanaugh
Publikováno v:
ACR Open Rheumatology, Vol 2, Iss 8, Pp 459-470 (2020)
ACR Open Rheumatology
ACR Open Rheumatology, 2020, ⟨10.1002/acr2.11156⟩
ACR Open Rheumatology
ACR Open Rheumatology, 2020, ⟨10.1002/acr2.11156⟩
OBJECTIVE Psoriatic arthritis (PsA) requires long-term treatment, yet safety concerns and monitoring requirements make maintenance a challenge. This analysis of pooled Psoriatic Arthritis Long-term Assessment of Clinical Efficacy (PALACE) 1, 2, and 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af41e432a10f189798b6e0b38a4874d5
https://doaj.org/article/fa93086f13fa47d6bce83b4a9731f08f
https://doaj.org/article/fa93086f13fa47d6bce83b4a9731f08f